Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal

Neuron

Volumn 82, Issue 6, 2014, Pages 1346-1356

  Matsui, Aya ^a   Jarvie, Brooke C ^b   Robinson, Brooks G ^a   Hentges, Shane T ^b   Williams, John T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE RECEPTOR; CHANNEL RHODOPSIN 2; DOPAMINE; DOPAMINE 2 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE RECEPTOR; RHODOPSIN; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EVOKED RESPONSE; FEMALE; GABAERGIC SYSTEM; IN VIVO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; POSTSYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SENSORY NERVE; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

AFFERENT PATHWAYS; ANALGESICS, OPIOID; ANIMALS; DOPAMINERGIC NEURONS; DRUG TOLERANCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; INFUSIONS, INTRAVENTRICULAR; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84902545813     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.04.030     Document Type: Article

References (58)

1. Bagley E.E., Gerke M.B., Vaughan C.W., Hack S.P., Christie M.J. GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron 2005, 45:433-445.
2. Bocklisch C., Pascoli V., Wong J.C.Y., House D.R.C., Yvon C., de Roo M., Tan K.R., Lüscher C. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science 2013, 341:1521-1525.
3. Bolam J.P., Smith Y. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res. 1990, 529:57-78.
4. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 1996, 16:631-639.
5. Bonci A., Williams J.T. Increased probability of GABA release during withdrawal from morphine. J.Neurosci. 1997, 17:796-803.
6. Britt J.P., McGehee D.S. Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens. J.Neurosci. 2008, 28:1672-1681.
7. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
8. Brown M.T.C., Tan K.R., O'Connor E.C., Nikonenko I., Muller D., Lüscher C. Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature 2012, 492:452-456.
9. Charara A., Smith Y., Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J.Comp. Neurol. 1996, 364:254-266.
10. Chieng B., Azriel Y., Mohammadi S., Christie M.J. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J.Physiol. 2011, 589:3775-3787.
11. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 1987, 32:633-638.
12. Chuhma N., Tanaka K.F., Hen R., Rayport S. Functional connectome of the striatal medium spiny neuron. J.Neurosci. 2011, 31:1183-1192.
13. Connor M., Borgland S.L., Christie M.J. Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br. J. Pharmacol. 1999, 128:1561-1569.
14. Cui Y., Ostlund S.B., James A.S., Park C.S., Ge W., Roberts K.W., Mittal N., Murphy N.P., Cepeda C., Kieffer B.L., et al. Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward. Nat. Neurosci. 2014, 17:254-261.
15. Dobi A., Margolis E.B., Wang H.-L., Harvey B.K., Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J.Neurosci. 2010, 30:218-229.
16. Ford C.P., Mark G.P., Williams J.T. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J.Neurosci. 2006, 26:2788-2797.
17. Fyfe L.W., Cleary D.R., Macey T.A., Morgan M.M., Ingram S.L. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J.Pharmacol. Exp. Ther. 2010, 335:674-680.
18. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 1983, 277:119-127.
19. Hack S.P., Vaughan C.W., Christie M.J. Modulation of GABA release during morphine withdrawal in midbrain neurons invitro. Neuropharmacology 2003, 45:575-584.
20. Hjelmstad G.O., Xia Y., Margolis E.B., Fields H.L. Opioid modulation of ventral pallidal afferents to ventral tegmental area neurons. J.Neurosci. 2013, 33:6454-6459.
21. Ingram S.L., Vaughan C.W., Bagley E.E., Connor M., Christie M.J. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J.Neurosci. 1998, 18:10269-10276.
22. Jalabert M., Bourdy R., Courtin J., Veinante P., Manzoni O.J., Barrot M., Georges F. Neuronal circuits underlying acute morphine action on dopamine neurons. Proc. Natl. Acad. Sci. USA 2011, 108:16446-16450.
23. Jarvie B.C., Hentges S.T. Expression of GABAergic and glutamatergic phenotypic markers in hypothalamic proopiomelanocortin neurons. J.Comp. Neurol. 2012, 520:3863-3876.
24. Jhou T.C., Geisler S., Marinelli M., Degarmo B.A., Zahm D.S. The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J.Comp. Neurol. 2009, 513:566-596.
25. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J.Neurosci. 1992, 12:483-488.
26. Kalivas P.W., Churchill L., Klitenick M.A. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 1993, 57:1047-1060.
27. Kaufling J., Veinante P., Pawlowski S.A., Freund-Mercier M.-J., Barrot M. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J.Comp. Neurol. 2009, 513:597-621.
28. Lammel S., Hetzel A., Häckel O., Jones I., Liss B., Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008, 57:760-773.
29. Lester J., Fink S., Aronin N., DiFiglia M. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res. 1993, 621:106-110.
30. Levitt E.S., Williams J.T. Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons. Mol. Pharmacol. 2012, 82:983-992.
31. Li W., Doyon W.M., Dani J.A. Quantitative unit classification of ventral tegmental area neurons invivo. J.Neurophysiol. 2012, 107:2808-2820.
32. Lobb C.J., Wilson C.J., Paladini C.A. A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J.Neurophysiol. 2010, 104:403-413.
33. Lowe J.D., Bailey C.P. Functional selectivity and time-dependence of mu-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area. Brit. J. Pharmacol 2014, Published online January 28, 2014. 10.1111/bph.12605.
34. Matsui A., Williams J.T. Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J.Neurosci. 2011, 31:17729-17735.
35. Nair-Roberts R.G., Chatelain-Badie S.D., Benson E., White-Cooper H., Bolam J.P., Ungless M.A. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 2008, 152:1024-1031.
36. North R.A., Vitek L.V. The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens. Br. J. Pharmacol. 1980, 68:399-405.
37. Omelchenko N., Sesack S.R. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J.Comp. Neurol. 2005, 483:217-235.
38. Pennock R.L., Hentges S.T. Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons. J.Neurosci. 2011, 31:281-288.
39. Pennock R.L., Dicken M.S., Hentges S.T. Multiple inhibitory G-protein-coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons. J.Neurosci. 2012, 32:10192-10200.
40. Perreault M.L., Hasbi A., Alijaniaram M., Fan T., Varghese G., Fletcher P.J., Seeman P., O'Dowd B.F., George S.R. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J.Biol. Chem. 2010, 285:36625-36634.
41. Quillinan N., Lau E.K., Virk M., von Zastrow M., Williams J.T. Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone. J.Neurosci. 2011, 31:4434-4443.
42. Schultz W. Behavioral dopamine signals. Trends Neurosci. 2007, 30:203-210.
43. Shoji Y., Delfs J., Williams J.T. Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal. J.Neurosci. 1999, 19:2347-2355.
44. Sim L.J., Selley D.E., Dworkin S.I., Childers S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J.Neurosci. 1996, 16:2684-2692.
45. Smith Y., Bolam J.P. The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J.Comp. Neurol. 1990, 296:47-64.
46. Steffensen S.C., Svingos A.L., Pickel V.M., Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J.Neurosci. 1998, 18:8003-8015.
47. Tan K.R., Yvon C., Turiault M., Mirzabekov J.J., Doehner J., Labouèbe G., Deisseroth K., Tye K.M., Lüscher C. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012, 73:1173-1183.
48. Tepper J.M., Lee C.R. GABAergic control of substantia nigra dopaminergic neurons. Prog. Brain Res. 2007, 160:189-208.
49. Tepper J.M., Martin L.P., Anderson D.R. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J.Neurosci. 1995, 15:3092-3103.
50. Thibault D., Loustalot F., Fortin G.M., Bourque M.-J., Trudeau L.-E. Evaluation of D1 and D2 dopamine receptor segregation in the developing striatum using BAC transgenic mice. PLoS ONE 2013, 8:e67219.
51. Tritsch N.X., Ding J.B., Sabatini B.L. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 2012, 490:262-266.
52. Ungless M.A., Magill P.J., Bolam J.P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 2004, 303:2040-2042.
53. Van Bockstaele E.J., Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 1995, 682:215-221.
54. van Zessen R., Phillips J.L., Budygin E.A., Stuber G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 2012, 73:1184-1194.
55. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873.
56. Williams J.T., Ingram S.L., Henderson G., Chavkin C., von Zastrow M., Schulz S., Koch T., Evans C.J., Christie M.J. Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 2013, 65:223-254.
57. Xia Y., Driscoll J.R., Wilbrecht L., Margolis E.B., Fields H.L., Hjelmstad G.O. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J.Neurosci. 2011, 31:7811-7816.
58. Yamaguchi T., Wang H.-L., Li X., Ng T.H., Morales M. Mesocorticolimbic glutamatergic pathway. J.Neurosci. 2011, 31:8476-8490.